Extensive activation of poly(ADP-ribose) polymerase-1 (PARP-1) by DNA damage is a major cause of caspase-independent cell death in ischemia and inflammation. Here we show that NAD ؉ depletion and mitochondrial permeability transition (MPT) are sequential and necessary steps in PARP-1-mediated cell death. Cultured mouse astrocytes were treated with the cytotoxic concentrations of N-methyl-N-nitro-N-nitrosoguanidine or 3-morpholinosydnonimine to induce DNA damage and PARP-1 activation. The resulting cell death was preceded by NAD ؉ depletion, mitochondrial membrane depolarization, and MPT. Sub-micromolar concentrations of cyclosporin A blocked MPT and cell death, suggesting that MPT is a necessary step linking PARP-1 activation to cell death. In astrocytes, extracellular NAD ؉ can raise intracellular NAD ؉ concentrations. To determine whether NAD ؉ depletion is necessary for PARP-1-induced MPT, NAD ؉ was restored to near-normal levels after PARP-1 activation. Restoration of NAD ؉ enabled the recovery of mitochondrial membrane potential and blocked both MPT and cell death. Furthermore, both cyclosporin A and NAD ؉ blocked translocation of the apoptosis-inducing factor from mitochondria to nuclei, a step previously shown necessary for PARP-1-induced cell death. These results suggest that NAD ؉ depletion and MPT are necessary intermediary steps linking PARP-1 activation to AIF translocation and cell death.
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PARP-1,
1 the most abundant of the poly(ADP-ribose) polymerase family members, is rapidly activated by DNA damage.
PARP-1 utilizes NAD
ϩ to form poly(ADP-ribose) polymers on specific acceptor proteins. PARP-1 activation appears to facilitate DNA repair under moderate stress conditions (3), but extensive PARP-1 activation promotes cell death under conditions that cause extensive DNA damage such as excitotoxicity and ischemia (2, 4) . Both genetic deletion and pharmacological inhibition of PARP-1 activity can markedly reduce cell death under these conditions (5) (6) (7) .
The sequence of events leading from PARP-1 activation to cell death has not been fully established. PARP-1-mediated cell death is caspase-independent, lacks many morphological hallmarks of classical apoptosis, and was long considered a direct result of energy failure (5, 8, 9) . Extensive PARP-1 activation causes NAD ϩ depletion, which, in turn, can lead to ATP depletion (5, 8, 10) . However, it has also been shown that translocation of the apoptosis-inducing factor (AIF) from mitochondria to the nucleus is required for PARP-1-mediated cell death (11) . Thus, a fundamental unanswered question is whether NAD ϩ depletion is a necessary and causal event in PARP-1-mediated cell death, and, if so, what is the link between NAD ϩ depletion and mitochondrial release of AIF.
Mitochondria permeability transition (MPT), like PARP-1 activation, is a significant factor leading to cell death after excitotoxicity, ischemia-reperfusion, and other disorders (12, 13) . MPT results from the opening of a large conductance channel in the inner mitochondrial membrane (14, 15) . Pharmacological inhibition of MPT with cyclosporin A (CsA) has been shown to prevent neuronal death after oxygen/glucose deprivation in vitro (16) and after ischemia or severe hypoglycemia in vivo (17) (18) (19) . MPT has also been shown to initiate nuclear apoptotic changes in a cell-free system (20) and is associated with the release of AIF in intact cells (21) (22) (23) . These findings suggest a potential mechanism for interplay between the cell death processes induced by PARP-1 and MPT.
Here we examined the relationships between PARP-1 activation, NAD ϩ depletion, MPT, and AIF translocation using primary astrocyte cultures. This primary culture preparation has proven useful for the study of PARP-1 cytotoxicity. Particularly important for the present study is that astrocytes permit passive transmembrane NAD ϩ influx through connexin hemichannels (24 -26) . This permits experimental control over intracellular NAD ϩ concentrations after PARP-1 activation. The results of these studies suggest that both NAD ϩ depletion and MPT are necessary intermediary steps in the cell death program leading from PARP-1 activation to AIF release and cell death.
cortices of wild type (WT) or PARP-1 Ϫ/Ϫ mice, as described previously (10) , in accordance with a protocol approved by the San Francisco Veterans Affairs Medical Center animal studies committee. WT mice were Swiss-Webster strain obtained from Simonsen (Gilroy, CA). The PARP-1 Ϫ/Ϫ mice were the 29 S Adprt1 tm1Zqw strain obtained from Jackson Laboratory (Bar Harbor, ME) and originally developed by Z. Q. Wang (27) . In brief, the cortices were harvested, freed of meninges, dissociated with papain digestion (with DNase) and subsequent trituration, and plated on 24-well Falcon culture plates or glass coverslips. Cells were treated for 48 h with 20 M cytosine arabinoside at confluence (12-15 days in vitro) to prevent microglial proliferation. This medium was replaced with Eagle's minimal essential medium supplemented with 3% fetal bovine serum (HyClone, Logan, UT), 2 mM glutamine, 100 nM sodium selenate, and 200 nM ␣-tocopherol. The astrocyte cultures were used, when confluent, at 20 to 30 days in vitro. At this age, any neurons that had been present in the initial plating have been killed by glutamate in the feeding medium (28) . The cultures contain Ͼ95% astrocytes and Ͻ5% microglia (29, 30) .
Experimental Procedures-Experiments were initiated by replacing the culture medium with a balanced salt solution (BSS) containing 3.1 mM KCl, 134 mM NaCl, 1.2 mM CaCl 2 , 1.2 mM MgSO 4 , 0.25 mM KH 2 PO 4 , 15.7 mM NaHCO 3 , and 2 mM glucose. The pH was adjusted to 7.2 while the solution was equilibrated with 5% CO 2 at 37°C. Osmolarity was verified at 280 -320 mosmol with a Wescor vapor pressure osmometer (Logan, UT). Drugs were added from concentrated stocks prepared in BSS immediately before use and adjusted to pH 7.2 when necessary. Exposures to N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) or 3-morpholinosydnonimine (SIN-1) were performed at 37°C in a 5% CO 2 atmosphere. Benzamide, 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone (DPQ; Calbiochem, San Diego, CA), CsA (Biomol, Plymouth Meeting, PA), and FK506 (Biomol, Plymouth Meeting, PA) were added at least 30 min prior to the addition of MNNG or SIN-1. Incubations were 30 min for MNNG (except where noted) or 60 min for SIN-1 and were terminated by washing and complete medium exchange. CsA and FK506 were re-added after the medium exchange. NAD ϩ was added only after medium exchange. Except where noted, the drugs were used at the following concentrations: 100 M MNNG; 5 mM SIN-1; 1 mM benzamide; 25 M DPQ; 200 nM CsA; 1 M FK506; and 10 mM NAD. NAD ϩ Measurements-Cultures were gently washed four times with cold BSS and then extracted with perchloric acid. NAD ϩ was measured using an enzymatic recycling assay (31) and normalized to total protein as measured by the bicinchonic acid method.
Assessment of Cell Death-Astrocyte death was quantified by measuring the lactate dehydrogenase (LDH) activity in the cell lysates of surviving cells 20 -24 h after the MNNG or SIN-1 exposures (10). Percentage of cell death in each well was calculated as (1 Ϫ (LDH activity)/(control LDH activity)) ϫ 100, with the control LDH activity defined as the mean value obtained in four control wells from the same 24-well plate as the test well. Control wells were treated with medium exchanges only, which causes no or negligible astrocyte death.
Detection of MPT-Astrocytes were loaded with calcein-acetoxymethylester (500 nM; Molecular Probes, Eugene, OR) and with MitoTrackerRed (500 nM; Molecular Probes) for 10 -30 s The dye loading was done prior to MNNG exposures. MitoTracker probes are cell-permeant, mitochondrion-selective dyes that have a thiol-reactive moiety that retains the dye within the mitochondria after loading (32) . Fluorescence was assessed with an inverted microscope equipped with a CCD digital camera (ORCA-ER; Hamamatsu Corporation, Bridgewater, NJ) at designated time points after incubation with the test compounds. Under the loading conditions employed, there was no baseline calcein signal in the mitochondria, obviating the need for cobalt quenching of the calcein signal (33) . Deconvolution and image overlays were performed using Openlab software (Improvision, Lexington, MA). For quantification, areas of red fluorescence (mitochondria) were identified as regions of interest. The calcein fluorescence in these regions was recorded as mean intensity per unit area and normalized to values obtained in control coverslips prepared in parallel. All values from each experiment, typically 10 -15 cells per coverslip, were pooled for each n.
Mitochondrial Membrane Potential-Astrocytes were loaded for at least 30 -60 min with 3 M 5,5Ј,6,6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethylbenzimidazolyl carbocyanine iodide (JC-1; Molecular Probes) and then imaged after dye loading. Monomer fluorescence was excited at 488 nm, and J-aggregate fluorescence was excited at 560 nm. Fluorescence values were collected as a field average for each excitation/emission pair, with 4 -10 fields assessed per coverslip. These values were averaged for each n and normalized to the values obtained from control coverslips prepared in parallel. Studies using tetramethylrhodamine (TMRM; Molecular Probes) to estimate the mitochondrial membrane potential (⌬ m ) of cells were performed under non-quench conditions as described previously (34) . Stock TMRM was prepared with dimethyl sulfoxide to a concentration of 1 mM, and this was diluted to 1-2 nM in recording buffer (BSS supplemented with PIPES, pH 7.2). The nonquench loading condition was established by loading cultures with a range of TMRM concentrations and confirming a fluorescence decrease after incubation with 10 M carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP), a mitochondrial uncoupler. In addition, FCCP was added at the end of each experimental recording to verify nonquench conditions (i.e. a decrease in TMRM fluorescence).
Immunocytochemistry-Immunostaining for poly(ADP-ribose) was performed on cells grown on glass cover slips and fixed in ice-cold trichloroacetic acid (5 min) and subjected to a sequential 70, 90, and 100% EtOH (5 min each). Monoclonal antibody for poly(ADP-ribose) (Trevigen, Gaithersburg, MD) was used at 1:2000 dilution. Immunostaining for AIF and voltage-dependent anion channel (VDAC, a mitochondrial marker) was performed on cells fixed with ice-cold acetone/ methanol (1:1) for 5 min. The antibodies for AIF (Santa Cruz Biotechnology, Santa Cruz, CA) and VDAC (Calbiochem) were used at 1:1500 dilutions. Immunostaining was visualized with fluorescencetagged secondary antibodies (Molecular Probes) and photographed with a Leica confocal laser microscope. Nuclear counterstaining with propidium iodide was performed after the removal of excess secondary antibody.
Statistics-Data are given as mean Ϯ S.E. Results were assessed by analysis of variance followed by the Student-Newman-Keuls post hoc test (InStat 3.0, GraphPad Software, San Diego, CA). p values were designated as * representing p Ͻ 0.01 and ** representing p Ͻ 0.001.
RESULTS

MNNG Induces PARP-1-mediated Cell Death-
The primary cortical astrocytes form a confluent layer of cells containing no neurons and Ͻ5% microglial cells (29, 30) . Astrocyte proliferation is inhibited by contact inhibition, and, consequently, the astrocyte cultures have a uniform density at confluency. DNA damage and PARP-1 activation were induced in the astrocyte cultures with the alkylating agent MNNG as described previously (9, 10, 31) . A 30-min incubation with 100 M MNNG reproducibly killed 50 -70% of the cells (Fig. 1A) as shown by an LDH assay 24 h after MNNG exposure. Cell death was a delayed process, with negligible death detected at 4 h, 5-15% of the cells dead at 6 h, and near maximal cell death at 16 h after MNNG exposure. MNNG-induced cell death was nearly eliminated in PARP-1 Ϫ/Ϫ cells and in WT cultures treated with the PARP inhibitors benzamide or DPQ (Fig. 1B) , confirming that the MNNG-induced cell death was mediated primarily by PARP-1 activation.
CsA Prevents PARP-1-mediated Cell Death-We used the potent MPT inhibitor CsA (35) to test whether MPT induction is required for PARP-1-mediated cell death. CsA prevented PARP-1-mediated cell death with an efficacy equivalent to that of the PARP inhibitors and an ED 50 of ϳ50 nM (Fig. 1B) . The possibility that this effect was due to CsA inhibition of calcineurin was excluded by the sub-micromolar concentrations of CsA employed and by the absence of cytoprotection in cultures treated with the calcineurin inhibitor FK506 (36). CsA did not inhibit poly(ADP-ribose) formation (Fig. 1C) , thereby excluding the possibility that CsA blocks PARP-1 mediated cell death by inhibiting PARP activity. Measures of cellular NAD ϩ content further showed that CsA concentrations up to 10 M had no effect on the NAD ϩ depletion induced by MNNG exposure (Fig.  1D ). These findings suggest that PARP-1 cytotoxicity in astrocytes is mediated through MPT induction.
PARP-1 Activation Leads to MPT Induction-More direct evidence for MPT in MNNG-treated astrocytes was obtained by the calcein dye exclusion method (37) . Calcein-acetoxymethylester is modified to its fluorescent form by cytosolic esterases, and, under the loading conditions employed, it is largely excluded from normal mitochondria ( Fig. 2A) but enters mitochondria after MPT induction. Astrocytes treated with MNNG exhibited a marked increase in mitochondrial calcein fluorescence, together with a rounding of mitochondrial morphology. There was also an associated shrinkage of cell and nuclear volume in most cells in which mitochondrial calcein fluorescence was prominent ( Fig. 2A) . None of these changes were in PARP-1 Ϫ/Ϫ astrocytes or in WT astrocytes pre-treated with the PARP inhibitor DPQ, suggesting that they resulted from PARP-1 activation. Importantly, these changes were also blocked by 200 nM CsA (but not 1 M FK506), supporting MPT as the route of calcein entry (Fig. 2, A and B) . MPT induction was a delayed process, rarely detected at 1 h after MNNG removal and inconsistently observed at 2 h after MNNG removal (data not shown), but fully manifest by 4 h after the MNNG incubations. At this time point, calcein fluorescence was evident in nearly every mitochondrion in the MNNGtreated WT astrocytes.
PARP-1 Activation Causes Mitochondrial Membrane Depolarization-TMRM was used to monitor ⌬ m under non-quenching conditions, such that reductions in mitochondrial fluorescence were indicative of ⌬ m depolarization (34, 38) . Activation of PARP-1 with MNNG led to a decrease in whole-cell TMRM fluorescence (Fig. 3A) . ⌬ m depolarization began during the 30-min MNNG incubation and continued for several hours after MNNG removal. Depolarization was markedly attenuated in cells treated with the PARP inhibitor DPQ. CsA did not significantly alter the decrease in TMRM fluorescence during MNNG exposure, but cells pre-treated with CsA were able to recover ⌬ m to near basal levels after MNNG exposure. FK506 had no effect on the MNNG-induced ⌬ m depolarization.
A separate series of experiments were performed using the fluorescent probe JC-1 to assess ⌬ m . As shown in Fig. 3B , the results obtained by the JC-1 method were in accord with those obtained with TMRM. Fig. 3C shows representative JC-1 images captured at 4 h after MNNG removal. Mitochondria in cells treated with MNNG showed an increase in monomer fluorescence and a decrease in J-aggregate fluorescence, indicating ⌬ m depolarization. As quantified in Fig. 3B , ⌬ m depolarization was not observed in PARP-1 Ϫ/Ϫ cells, cells treated with the PARP inhibitor DPQ, or in cells treated with CsA. To exclude the possibility that changes in TMRM or JC-1 fluorescence were an indirect effect of plasma membrane depolarization, a separate set of cultures were exposed to medium containing 50 mM K ϩ either with or without 2.5 mM Ca 2ϩ . In the absence of Ca 2ϩ , the 50 mM K ϩ medium caused no change in JC-1 fluorescence and only negligible change in TMRM fluorescence (not shown), confirming that plasma membrane potential had a minimal effect on the fluorescence signals (39) . NAD ϩ Repletion Prevents MPT and Prevents PARP-1-mediated Astrocyte Death-Extensive activation of PARP-1 consumes NAD ϩ and depletes adenine nucleotide pools (2, 8, 10) . Adenine nucleotide depletion is one of several factors that can promote MPT (15, 40) . To determine whether NAD ϩ depletion mediates PARP-1-induced MPT, we restored NAD ϩ concentrations to near-normal levels in MNNG-treated astrocytes by adding exogenous NAD ϩ to the culture medium (24 -26) (Fig.  1D) . The NAD ϩ depletion that normally results from PARP-1 activation was negated by the addition of 10 mM NAD ϩ to the medium immediately after MNNG washout. Astrocytes treated in this manner did not exhibit MPT (Fig. 2) , and NAD ϩ repletion reduced MNNG-induced astrocyte death to an extent comparable with that achieved with PARP inhibitors or CsA (Fig.  4A) . The possibility of direct or indirect inhibition of PARP-1 by NAD ϩ repletion was excluded, because NAD ϩ did not block poly(ADP-ribose) formation (Fig. 1C) and also because NAD 
PARP-1-mediated Cell Death Requires NAD Depletion and MPT
but, under conditions of ischemia and inflammation, it is peroxynitrite and other reactive oxygen species that are primarily responsible for DNA damage and PARP-1 activation (4, 41). To confirm the physiological relevance of the MNNG model, astrocyte cultures were treated with SIN-1, which forms superoxide, nitric oxide, and peroxynitrite in oxygenated solutions. As shown in Fig. 4B , the results obtained using SIN-1 were similar to those obtained using MNNG (Figs. 4A and 1, A and B) , with both CsA and NAD ϩ reducing astrocyte death to a degree comparable with the PARP inhibitors. Similarly, SIN-1 at this concentration (10 mM) was not cytotoxic to astrocytes cultured from PARP-1 Ϫ/Ϫ mice (Fig. 4B ).
The effect of NAD ϩ repletion on astrocyte ⌬ m was followed with TMRM, as shown in Fig. 5 . Activation of PARP-1 with MNNG caused a rapid initial depolarization of ⌬ m , followed by a slower continued depolarization after MNNG removal (Figs.  3A and 5A ). The addition of NAD ϩ after MNNG removal stopped the decline in TMRM fluorescence and led to a slow normalization of ⌬ m , as would be expected in cells that will survive. The ⌬ m changes in individual mitochondria were not uniform within or between cells. To characterize this heterogeneous response, the fluorescence values of individual mitochondria at 4 h after MNNG washout were quantified, binned according to normalized TMRM fluorescence, and plotted as a histogram (Fig. 5B) . A minor degree of ⌬ m heterogeneity was observed under basal conditions, but a majority (Ͼ 90%) of the mitochondria had a TMRM fluorescence ratio within 10% of the population mean. At 4 h after MNNG incubation there was a left-shift of the histogram toward lower TMRM fluorescence, as well as a dispersion of the individual mitochondrial TMRM fluorescence values. Mitochondria in cultures treated with NAD ϩ following the MNNG exposures were, on average, rightshifted compared with MNNG alone, indicating a recovery of ⌬ m . These studies of individual mitochondria were facilitated by the relative lack of intracellular mitochondrial movement during the course of these studies. In contrast to neurons (42) , Ͻ5% of the mitochondria moved out of the regions of interest identified in the initial fluorescence image, a difference possibly due, in part, to the very flat shape of astrocytes. The number of moving mitochondrial was not obviously altered by experimental conditions.
CsA and NAD ϩ Repletion Prevent PARP-1-induced AIF Translocation-Because AIF translocation has also been identified as a mediator of PARP-1-induced cell death, (11), we also examined the relationships between PARP-1 activation, MPT, and AIF translocation. Double labeling of AIF and the mitochondria-specific VDAC 4 h after MNNG exposure confirmed that AIF translocated to the nucleus after PARP-1 activation and that this translocation was blocked by PARP-1 inhibition (Fig. 6, A and B) . AIF translocation was also prevented in cells in which MPT was blocked by CsA or NAD ϩ , suggesting that AIF translocation requires MPT. A time course of the AIF translocation is shown in Fig. 6C . These time points can be compared with time points at which NAD ϩ repletion can preserve astrocyte viability (Fig. 7) . The two curves are nearly inverse images of one another, suggesting that NAD ϩ is ineffective in preserving cell viability once MPT has occurred. DISCUSSION These results suggest that both NAD ϩ depletion and MPT are necessary events in the sequence leading from PARP-1 activation to cell death. The findings support a complex interaction between the nuclear and mitochondrial cell death programs during PARP-1 activation, whereby nuclear DNA damage triggers PARP-1 activation and NAD ϩ depletion, NAD ϩ depletion leads to MPT, and MPT, in turn, leads to nuclear AIF translocation and cell death. Although MNNG has been widely used to selectively induce PARP-1 activation (9 -11, 43, 44) , this alkylating agent might have additional effects that could contribute to MPT or cell death, such as activation of other PARP family members or direct effects on mitochondria. To exclude this possibility here, we showed that MNNG-induced cell death was completely blocked by two structurally different PARP inhibitors. In addition to pharmacological inhibition of PARP-1, the role of PARP-1 activation in MNNG-induced genotoxicity has been further confirmed by using astrocytes prepared from PARP-1 Ϫ/Ϫ mice. NAD ϩ depletion was also largely attenuated by these conditions, such that the effects of MNNG on cell death and NAD ϩ levels can be interpreted as primarily attributable to PARP-1 activity. In addition, peroxynitrite-mediated damage to DNA is thought to be the primary cause of PARP-1 activation in excitotoxicity and cerebral ischemia (4, 45) , and the results of cell viability studies performed using the peroxynitrite generator SIN-1 were very similar to those obtained using MNNG.
MPT was visualized and quantified using the calcein dye method described by Petronilli et al. (33) . This method is based on the fact that, under specified conditions, calcein is excluded from mitochondria but gains access through the large pore formed during MPT. Under the conditions of the present studies, calcein was excluded from mitochondria in normal astrocytes and entered mitochondria after PARP-1 activation. Calcein entry into mitochondria was blocked by the MPT inhibitor CsA at a concentration of 200 nM, further indicating that MPT is the route of calcein entry. Sub-micromolar concentrations of CsA inhibit MPT through its effects on cyclophilin D, (46, 47) , but CsA at higher concentrations can also have other effects. In particular, CsA concentrations above 1 M can inhibit calcineurin and thereby influence inducible nitric oxide synthase (iNOS) activity and other processes that influence cell death (48) . CsA was used at concentrations of 200 nM or less in the present studies, and none of the effects attributed to CsA were reproduced by 1 M FK506, which inhibits calcineurin but not cyclophilin D (48). These observations support the conclusion that the observed effects of CsA on mitochondrial calcein entry and cell death were due to MPT inhibition.
Prior studies have documented a correlation between PARP-1-induced cell death and NAD ϩ depletion (4, 8, 11, 31) ; however, without an effective means of manipulating intracellular NAD ϩ , it has been difficult to ascertain whether the NAD ϩ depletion is a causative event in PARP-1-induced cell death or merely an epiphenomenon. This uncertainty was underscored by the finding that AIF translocation mediates cell death after PARP-1 activation (11), because NAD ϩ depletion is not known to be required for AIF translocation in other settings. Liposome delivery of NAD ϩ to fibroblasts prior to PARP activation with SIN-1 was recently reported to partially preserve mitochon- drial membrane potential (49) . In the present study we were able to maintain NAD ϩ concentrations in astrocytes at nearnormal levels after PARP-1 activation by using the capacity of this cell type to passively conduct NAD ϩ through connexin-43 hemichannels (24, 25) . NAD ϩ repletion prevented the cell death that would otherwise occur in MNNG-and SIN-1-treated cells, suggesting that NAD ϩ depletion plays an essential role in the PARP-1 cell death pathway.
Intracellular NAD ϩ is segregated into cytosolic and mitochondrial pools that do not readily interchange (50) , and previous reports suggest that PARP-1 activation leads to an initial, preferential depletion of the cytosolic NAD ϩ pool. Cytosolic NAD ϩ is an essential co-factor at the lactate dehydrogenase step and at the glyceraldehydes-3-phosphate dehydrogenase step of glycolysis. Glycolysis is almost completely blocked in astrocytes after PARP-1 activation, and this blockade is reversed by NAD ϩ repletion (26) . It has also been shown that astrocytes (and neurons) can be rescued from PARP-1-induced cell death by metabolic substrates such as pyruvate that bypass glycolysis (10) . These substrates are oxidized in the mitochondrial tricarboxylic acid cycle, suggesting that the mitochondrial NAD ϩ pool is preserved for a period of time after PARP-1 activation (10). These observations are consistent with the fact that mitochondria NAD ϩ is not normally accessible to the cytosol and therefore cannot normally serve as substrate for PARP-1. It has been proposed, however, that MPT permits the egress of mitochondrial NAD ϩ (50, 51) and that this may lead to a later, potentially irreversible loss of NAD ϩ from the mitochondrial compartment.
Importantly, MNNG-treated astrocytes in which NAD ϩ was maintained near normal levels did not exhibit MPT or cell death, suggesting that NAD ϩ is essential in the link between PARP-1 activation and MPT. NAD ϩ does not directly influence MPT, but NAD ϩ depletion may promote MPT by several indirect mechanisms. ATP and ADP are important endogenous inhibitors of MPT, (40) , and these purines are consumed during NAD ϩ synthesis (5, 8, 9) . Another factor promoting MPT may be impaired substrate delivery to mitochondria, because NAD ϩ is an essential for flux though the glycolytic pathway to the mitochondria (10) . Impaired substrate delivery may also contribute to ⌬ m depolarization, which, in turn, promotes MPT (35) .
Studies using both the TMRM and JC-1 dye methods showed that PARP-1 activation induced ⌬ m depolarization before MPT was detected. CsA did not block this initial depolarization, further suggesting that the depolarization preceded rather than resulted from MPT. Moreover, NAD ϩ added after PARP-1 activation permitted ⌬ m recovery and prevented the subsequent induction of MPT. As shown in Fig. 5 , there was a heterogeneity observed in the response of mitochondria to NAD ϩ repletion, similar to the heterogeneous responses to other depolarizing stimuli reported previously (52, 53) . A detailed analysis of this heterogeneity was not conducted, but there was no evidence for an "all or none" effect of MNNG or NAD ϩ on ⌬ m within individual cells. Each of the factors found to prevent MNNG-induced cell death, i.e. PARP inhibitors, PARP-1 Ϫ/Ϫ genotype, NAD ϩ repletion, and CsA, were also found to prevent AIF translocation, supporting the concept that AIF translocation is a crucial step in the PARP-1 cell death pathway (11) . Inhibition of MPT with either CsA or Bcl-2 overexpression has been previously shown to block AIF release in a cell-free mitochondria system (23) and in tumor cell lines (54, 55) . Because AIF is normally localized within the mitochondrial intermembrane space (56), this suggests the possibility that MPT may provide a route for AIF release (22) . It is also possible, however, that MPT or the associated collapse of mitochondrial membrane potential leads to AIF release by more indirect routes.
Although many studies have localized PARP-1 exclusively to the nucleus (1, 6, 7, 10, 11, 57, 58) , a recent study suggests that PARP-1 may also be localized to mitochondria (49) . PARP-1 localization to mitochondria could permit direct interactions between PARP-1 and mitochondrial components involved in MPT. This would obviate the need for a cytosolic signal such as NAD ϩ depletion to link nuclear and mitochondrial events. Mitochondrial localization of PARP-1 would remain consistent with the principal conclusions presented here, namely, that NAD ϩ depletion and MPT are both necessary steps in the PARP-1 cell death pathway.
